Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system. Evidence from family studies indicates a strong genetic component. Despite many studies of candidate genes, only an association with the HLA-DRB1*1501-DQB1*0602 haplotype has been generally detected, and HLA linkage established by transmission disequilibrium testing. A genome-wide scan revealed suggestive linkage of MS with markers on chromosome 7p15 in HLA-DR15-nonsharing British families, in a region syntenic to a locus predisposing to experimental autoimmune encephalomyelitis in the rat. We therefore tested the 7p15 region as a candidate region for genetic susceptibility to MS in 104 French families with at least two affected siblings. We found evidence suggestive of a predisposing locus in families in which only one affected sibling or none of them carry the HLA-DR15 allele. Comparison of the results of the British and French groups suggests that the region of interest can be narrowed to a 2.45-cM interval.
Introduction
Multiple sclerosis (MS) is a chronic inflammatory disorder characterized by multifocal damage of myelin in the central nervous system (CNS). The prevalence of this putative autoimmune disease is 0.1% in individuals of northern European origin. The pattern of disease in families is inconsistent with a single gene model, but population-based studies have shown that the risk is considerably higher in the first-degree relatives of an affected individual than in the general population, and the recurrence in siblings can be as high as 5%. Although this clustering could reflect shared environmental factors, there is substantial evidence supporting a genetic interpretation. Indeed, there is a higher concordance rate in monozygotic (30%) than in dizygotic twins (4%), there is no excess risk in the nonbiological relatives of adopted cases, although excess risk is seen in biological relatives of these cases, there is no effect on the sibling recurrence risk from birth order, the risk is lower in half-siblings than in full siblings, and the risk of disease is much higher in offspring born to couples who both have multiple sclerosis than in the offspring of those where only one parent has the disease.
1 Despite many studies of candidate genes, only an association with the HLA-DRB1*1501-DQB1*0602 haplotype has been generally detected, 2 and HLA linkage with MS established by transmission disequilibrium testing. 3 The number of susceptibility genes remains unknown.
Given the immunopathological similarities between experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis, this animal model provides a useful alternative to identify candidate loci whose human homologs may potentially be involved in MS susceptibility. 4 It is most probable, indeed, that these conditions share common genes predisposing to demyelination diseases of CNS. This approach has already been successfully applied to the mapping of an MS vulnerability locus on chromosome 5, in a region syntenic to the murine locus Eae2. 5 By the genome scan of an experimental cross between the susceptible Lewis and resistant Brown Norway rats, we previously identified two non-MHC regions that significantly contributed to EAE, one near the centromere of chromosome 4 and the other on the long arm of chromosome 10. 6 The human syntenic region for the EAE locus on rat chromosome 4 maps to 7p15. Interestingly, suggestive linkage of MS with markers on 7p15 was revealed by a genome-wide scan in MS families from the United Kingdom. 7, 8 In the present study, the 7p15 region was therefore tested as a candidate region for genetic susceptibility to MS in 104 French families (116 affected sib pairs). These families were collected from university and community hospitals and private practitioners throughout the country. Ascertainment criteria were: (1) at least two sibs affected, (2) confirmation of all cases by clinical exam, medical records review, laboratory testing, and/or paraclinical studies such as MRI scanning or evoked response testing using strict diagnostic criteria, 9 and (3) signed informed consent. The characteristics of the families investigated in this study are given in Table 1 .
Results and discussion
Genotyping of the microsatellite markers D7S513, D7S2557, D7S493, D7S2458, D7S682, D7S629, D7S673, D7S526, and D7S484 was performed by a fluorescentbased detection system as described previously. 10 These nine markers span over a 36 cM region on chromosome 7p15. Multipoint model-free linkage analysis was conducted using MERLIN. 11 Overall, we did not find strong evidence for an MS susceptibility locus in this region (Table 2 ), although the LOD score peak reached 1.72 at D7S2458, a value that exceeds the threshold of 0.7 for a nominal significance level of 5%.
To take into account the possible epistatic effect of the only confirmed HLA linkage and association in MS, multipoint analyses were run on these data after stratifying the families based on the occurrence of the HLA-DR15 allele in affected individuals. In all, 42 sibling pairs in which the two affected sibs have the HLA-DR15 allele compose the HLA-DR15-positive group. A total of 68 sibling pairs in which only one affected (N¼18) or none of them (N¼50) carry the HLA-DR15 allele compose the HLA-DR15-negative group. Six families could not be classified due to missing data. It is noteworthy that suggestive evidence of linkage, as defined by Lander and Kruglyak, 12 was obtained in the HLA-DR15-negative subset of families, where chromosome 7p15 indeed yielded a peak LOD score of 2.69 at D7S2458 (Table 2 ). In HLA-DR15-positive families, the LOD score generated at this marker was only 0.15. It is of special interest that a genome-wide scan of MS A total of 104 families of French ancestry, yielding the equivalent of 116 sib pairs, were included in the study. The distribution of the two major clinical subtypes, primary progressive (progression from onset) and relapsing-remitting/secondary progressive MS, is given for affected male and female siblings separately. Blood from all available parents and from unaffected siblings where parents were missing was sampled as well. A total of 480 individuals were genotyped for the nine microsatellite markers. HLA-DRB1 genotyping was performed using reverse dot blot hybridization. As previously reported, 3 the pedigree disequilibrium test indicates significant transmission distortion of the HLA-DR15 allele (w 2 ¼15.05; 1 df; P¼0.0001) in this family set. Map distances between markers were obtained from the Center for Medical Genetics at the Marshfield Medical Research Foundation (http:// research.marshfieldclinic.org/genetics/). Genotyping was achieved by PCR amplification of each microsatellite followed by electrophoresis on an ABI 377 DNA sequencing machine, with allele sizing performed using GENESCAN and GENOTYPER softwares (ABI, Forster City, CA, USA). Multipoint model-free linkage analysis was conducted using MERLIN, 11 which computes at each location the Kong and Cox LOD score and P-value, 25 based on allele sharing among affected individuals.
Linkage and association of multiple sclerosis to 7p15 H Coppin et al performed on an independent series of British families 7, 8 also showed evidence for linkage with a marker in this region, and that this linkage clusters with the non-DR15-sharing families (MLSE2.3 for marker D7S516). The region with the strongest evidence for linkage in our HLA-DR15-negative families is located about 5 cM telomeric to the region with the strongest evidence in the UK study, 8 and there is overlap in the 1-LOD-unit support intervals for the two affected sib-pair studies. It is therefore likely that the two studies highlight the same MS predisposing gene in this region of chromosome 7. This region is flanked by hits on one side from the Swedish group 13 and on the other side from the Sardinian and Italian groups, 14 and is, therefore, a particularly promising region for further study.
In order to investigate further the possible significance of the segregation seen in the conditional analyses, we used transmission disequilibrium testing with the HLA-DR15-negative families to look for evidence of linkage disequilibrium across the 7p15 region. Information was gained from nuclear families in which there were two affected children and both parents genotyped, and at least one parent heterozygous, as well as from discordant sibships with at least one affected and one unaffected sibling with different marker genotypes, even if parental genotype data were not available. Each of the microsatellite markers was tested for evidence of transmission disequilibrium using the pedigree disequilibrium test for multiple markers implemented in PDT 4.0. 15, 16 We also performed linkage disequilibrium tests based on genotypes (geno-PDT), which are presumably more powerful when the disease alleles at a locus do not act additively on disease risk. 17 PDT 4.0 computes both allele/genotype-specific statistics and global statistics that account for multiple testing. The pedigree disequilibrium test is a valid test of association, even though it uses all potentially informative data in the families. 15 Two markers, D7S2458 and D7S673, showed significant association with MS by either the pedigree disequilibrium test or the genotype-based association test, providing evidence for linkage disequilibrium with the disease locus over the investigated region. Indeed, allele 15 at locus D7S673 showed a significant transmission distortion (Z¼3.37; 1 df; P¼0.0007), even when controlling for multiple allele testing (global PDT: w 2 ¼20.90; 11 df; P¼0.03). Moreover, genotype 5/13 at locus D7S2458 was significantly associated with MS (Z¼2.73; 1 df; P¼0.006), even when controlling for multiple genotype testing (global geno-PDT: w 2 ¼24.98; 15 df; P¼0.05). The relatively small level of significance for the global tests results from the large number of alleles and genotypes observed at these very polymorphic loci, and the fact that such tests are generally more appropriate for analyzing linkage disequilibrium in family data at SNPs than at microsatellite markers. 18 Interestingly, marker D7S2458 for which significant linkage disequilibrium has been shown by geno-PDT is the locus with the strongest evidence for linkage in our MS-affected sib-pair multipoint analysis, and is located only 2.45 cM from the D7S673 locus for which significant linkage disequilibrium was found by PDT. The disequilibrium testing and the linkage results are therefore consistent with each other. Of further interest is the significant excess of transmission of the 202-bp allele at marker D7S629 from parents to MS-affected offspring observed in the British HLA-DR15-non-sharing families, 8 since this latter marker lies within the D7S2458-D7S673 interval.
In summary, the finding of convergent results in two independent sets of HLA-DR15-non-sharing families supports the existence of an MS-susceptibility locus in this region. Speculations on different steps in the pathogenesis, which depend primarily on T-cell-dependent (DR15-sharing) or antibody-mediated (DR15-nonsharing) mechanisms, can be made, with different pathogenic models converging on the indistinguishable phenotype of clinically definite multiple sclerosis. The significant transmission disequilibrium test at the D7S629 microsatellite locus in the British families, and the significant geno-PDT at marker D7S2458 and PDT at marker D7S673 in the French families suggest that the region of interest can be narrowed to the vicinity of these three markers which lie within a 2.45-cM interval and that there may be limited ancestral predisposing alleles for MS in that region. These allelic associations should greatly facilitate the cloning of the putative susceptibility gene on 7p15. Several genes map in this region, some of which, like the IL-6 and the NPY genes, can be potential candidates. Several studies indeed suggest that IL-6 plays an important role in the regulation of the inflammatory CNS response in EAE and MS. For example, IL-6-deficient mice are resistant to the induction of MOG-induced EAE, 19 and the administration of neutralizing anti-IL-6 antibodies reduces the severity of clinical disease in an MBP-induced EAE model. 20 In MS patients, increased serum concentrations of soluble IL-6 receptor 21 as well as elevated levels of IL6 mRNA in peripheral blood lymphocytes 22 suggest that a dysregulation of IL-6 might contribute to MS pathogenesis. Very recently, NPY was shown to be a potent immunomodulator able to induce a Th2 shift in vitro and to suppress significantly the clinical course of EAE. 23 Given that the levels of NPY in the cerebrospinal fluid of MS patients are reduced, 24 it is tempting to speculate that NPY may also play a critical role in preventing the development of MS. These candidate genes should therefore be examined in priority.
